Promising Drug Trial Lifts Stock of Intercept
Friday, January 10, 2014 - 12:30
in Health & Medicine
The trial, which was cut short, showed that Intercept Pharmaceuticals might have a treatment for a fatty liver disease.
Updated by artificial intelligence Sat, 3 Jan 2026, 15:40:35 UTC Learn more
- Tell your friends
- Get science news via